Isola Therapeutics
UEI: M3QDM72NME75
• CAGE: 890E6
Overview
Awardee Type
Parent
Name
Isola Therapeutics
Website
Headquarters
Minneapolis, MN
United States
United States
Most Recent Award
May 1, 2026
Calculating
Federal contract recipient
ISOLA THERAPEUTICS INC
(UEI M3QDM72NME75, CAGE 890E6)
is headquartered in Minneapolis MN.
Its primary registered NAICS is 339112 Surgical and Medical Instrument Manufacturing.
The corporation
was founded in May 2018 and
federally registered in
February 2019.
Federal Award Analysis
Isola Therapeutics federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
ISOLA THERAPEUTICS INC
UEI
M3QDM72NME75
CAGE Code
890E6
Primary NAICS
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
May 1, 2018
Initial Registration
Feb. 27, 2019
Last Registration
Nov. 12, 2025
Registration Activation
Nov. 12, 2025
Registration Expiration
Nov. 10, 2026
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
MN
Country of Incorporation
USA
Employees
<500
Reported NAICS
Reported PSC
Accepts Credit Cards
No